DRTSW Alpha Tau Medical Ltd. Warrant
$3.54▲ +0.00%
Healthcare
Other
Volume 2.7K
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
3.10 - 3.54
% vs 50 MA
-6.92%
% vs 200 MA
–%
RSI-14
50.1
MACD Histogram
-0.0200
Beta (1Y vs SPY)
-1.01
Gross Rev
$0
Gross Profit
$0
EBITDA
-$55.05M
COGS
–
Operating Exp
$13.78M
Operating Income
-$13.78M
EBIT
-$13.78M
Pretax Income
-$45.58M
Net Income
-$45.81M
Price & Volume History
Loading chart…
Recent News
Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea
GlobeNewswire · Oct 22, 2026 8:30 AM ET
How Investors Are Reacting To Alpha Tau Medical (DRTS) Expanded Brain Cancer Trial
Simply Wall St. · Oct 20, 2026 9:18 PM ET
Alpha Tau Medical Gets FDA Approval to Expand Brain Cancer Trial
MT Newswires · Oct 19, 2026 9:05 AM ET
Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
GlobeNewswire · Oct 19, 2026 8:30 AM ET
Alpha Tau to Participate in October Investor Conferences
GlobeNewswire · Oct 5, 2026 9:45 AM ET
Alpha Tau to Participate in September Investor Conferences
GlobeNewswire · Sep 2, 2026 8:00 AM ET
Alpha Tau Medical Completes Patient Enrollment in Pancreatic Cancer Study
MT Newswires · Aug 31, 2026 8:29 AM ET
Alpha Tau Medical Files for Dual Listing on Tel Aviv Stock Exchange
MT Newswires · Aug 10, 2026 9:25 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See DRTSW's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.